The association of anti-tumor necrosis factor and thiopurine therapy with the risk of lymphoma among Inflammatory Bowel Disease patients: A nation-wide study from the epi-IIRN

被引：0
|
作者：
Waterman, M. [1 ]
Lavi, I. [2 ]
Harel, S. [3 ]
Focht, G. [3 ]
Weisband, J. Loewenberg [4 ]
Greenfeld, S. [5 ]
Kariv, R. [5 ]
Ledderman, N. [6 ]
Matz, E. [7 ]
Keinan-Boker, L. [8 ]
Eizenstein, S. [9 ]
Dotan, I. [10 ]
Turner, D. [3 ]
Levi, Z. [10 ]
机构：
[1] Technion Israel Inst Technol, Dept Gastroenterol, Rambam Hlth Care Campus, Rappaport Fac Med, Haifa, Israel
[2] Lady Davis Carmel Med Ctr, Dept Community Med & Epidemiol, Haifa, Israel
[3] Hebrew Univ Jerusalem, Juliet Keidan Inst Pediat Gastroenterol Hepatol &, Shaare Zedek Med Ctr, Jerusalem, Israel
[4] Clalit Hlth Serv, Clalit Res Inst, Chief Phys Off, Tel Aviv, Israel
[5] Tel Aviv Univ, Maccabi Hlth Serv, Sackler Fac Med, Tel Aviv, Israel
[6] Meuhedet, Hlth Serv, Tel Aviv, Israel
[7] Leumit, Hlth Serv, Tel Aviv, Israel
[8] Univ Haifa, Sch Publ Hlth, Haifa, Israel
[9] Tel Aviv Univ, Sch Publ Hlth, Sackler Fac Med, Tel Aviv, Israel
[10] Tel Aviv Univ, Div Gastroenterol, Rabin Med Ctr Petah Tikva, Sackler Fac Med, Tel Aviv, Israel
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP72
引用
收藏
页码：I115 / I1116
页数：2
相关论文
共 50 条
  • [1] Risk of Cancer in Paediatric onset Inflammatory Bowel Diseases: A Nation-wide Study From the epi-IIRN
    Atia, Ohad
    Harel, Sasha
    Ledderman, Natan
    Greenfeld, Shira
    Kariv, Revital
    Dotan, Iris
    Balicer, Ran
    Silverman, Barbara
    Matz, Eran
    Levi, Zohar
    Waterman, Matti
    Fried, Iris
    Rowe, Jacob M.
    Turner, Dan
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 (05): : 786 - 795
  • [2] Anti-tumor Necrosis Factor Drugs and Risk of Lymphoma in Patients with Inflammatory Bowel Disease
    Blandizzi, C.
    Tuccori, M.
    Ferraro, S.
    Leonardi, L.
    Convertino, I.
    [J]. DRUG SAFETY, 2019, 42 (10) : 1245 - 1245
  • [3] Association of Anti-Tumor Necrosis Factor Therapy With Mortality Among Veterans With Inflammatory Bowel Disease
    Cohen-Mekelburg, Shirley
    Wallace, Beth I.
    Van, Tony
    Wiitala, Wyndy L.
    Govani, Shail M.
    Burns, Jennifer
    Lipson, Rachel
    Yun, Huifeng
    Hou, Jason
    Lewis, James D.
    Dominitz, Jason A.
    Waljee, Akbar K.
    [J]. JAMA NETWORK OPEN, 2021, 4 (03)
  • [4] The Association of Inflammatory Bowel Disease with Coeliac Disease and Coeliac Autoimmunity in Children and Adults: A Nationwide Study from the epi-IIRN
    Kori, Michal
    Zamir, Yonatan
    Yermiyahu, Sami Or
    Ainbinder, Inessa
    Daichman, Svetlana
    Pinto, Gavriel David
    Weisband, Yiska Loewenberg
    Greenfeld, Shira
    Kariv, Revital
    Lederman, Natan
    Matz, Eran
    Shamir, Raanan
    Dotan, Iris
    Turner, Dan
    [J]. JOURNAL OF CROHNS & COLITIS, 2023, 17 (05): : 700 - 705
  • [5] Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease
    Peter, Inga
    Dubinsky, Marla
    Bressman, Susan
    Park, Andrew
    Lu, Changyue
    Chen, Naijun
    Wang, Anthony
    [J]. JAMA NEUROLOGY, 2018, 75 (08) : 939 - 946
  • [6] Impact of thiopurine dose in anti-tumor necrosis factor combination therapy on outcomes in inflammatory bowel disease
    Nawaz, Ahmad
    Glick, Laura R.
    Chaar, Abdelkader
    Li, Darrick K.
    Gaidos, Jill K. J.
    Proctor, Deborah D.
    Al-Bawardy, Badr
    [J]. ANNALS OF GASTROENTEROLOGY, 2023, 36 (01): : 39 - +
  • [7] Pregnancy outcome in women with inflammatory bowel disease treated with anti-tumor necrosis factor and/or thiopurine therapy: a multicenter study from Japan
    Komoto, Shunsuke
    Motoya, Satoshi
    Nishiwaki, Yuji
    Matsui, Toshiyuki
    Kunisaki, Reiko
    Matsuoka, Katsuyoshi
    Yoshimura, Naoki
    Kagaya, Takashi
    Naganuma, Makoto
    Hida, Nobuyuki
    Watanabe, Mamoru
    Hibi, Toshifumi
    Suzuki, Yasuo
    Miura, Soichiro
    Hokari, Ryota
    [J]. INTESTINAL RESEARCH, 2016, 14 (02) : 139 - 145
  • [8] Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease
    Frank Hoentjen
    Ad A van Bodegraven
    [J]. World Journal of Gastroenterology, 2009, 15 (17) : 2067 - 2073
  • [9] Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease
    Hoentjen, Frank
    Van Bodegraven, Ad A.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (17) : 2067 - 2073
  • [10] Burden of depression and anxiety among inflammatory bowel disease patients in a national cohort in Israel - Data from the EPI-IIRN
    Mekori-Domachevsky, E.
    Ziv-Baran, T.
    Weisband, Y. Loewenberg
    Greenfeld, S.
    Kariv, R.
    Erez, M.
    Friss, F.
    Focht, G.
    Turner, D.
    Ben-Horin, S.
    Kopylov, U.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I580 - I581
12345